Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

257
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
257
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

215
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
215
Alcohols from Carbonyl Compounds: Reduction02:23

Alcohols from Carbonyl Compounds: Reduction

12.1K
Reduction is a simple strategy to convert a carbonyl group to a hydroxyl group. The three major pathways to reduce carbonyls to alcohols are catalytic hydrogenation, hydride reduction, and borane reduction.
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...
12.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.0K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Using Gene Expression Changes for Monitoring Glioblastoma WHO CNS Grade 4 Recurrence: Validation of NGS Candidate Genes via qRT-PCR.

Radiation research·2026
Same author

Development of a Point-of-Care Microfluidic RNA Extraction Slide for Gene Expression Diagnosis after Irradiation.

Radiation research·2024
Same author

Applicability of Gene Expression in Saliva as an Alternative to Blood for Biodosimetry and Prediction of Radiation-induced Health Effects.

Radiation research·2024
Same author

Validating a Four-gene Set for H-ARS Severity Prediction in Peripheral Blood Samples of Irradiated Rhesus Macaques.

Radiation research·2024
Same author

PUM1 and PGK1 are Favorable Housekeeping Genes over Established Biodosimetry-related Housekeeping Genes such as HPRT1, ITFG1, DPM1, MRPS5, 18S rRNA and Others after Radiation Exposure.

Radiation research·2024
Same author

Validating Radiosensitivity with Pre-Exposure Differential Gene Expression in Peripheral Blood Predicting Survival and Non-Survival in a Second Irradiated Rhesus Macaque Cohort.

Radiation research·2024
Same journal

Outcomes of Methadone and Buprenorphine Maintenance Treatments in Opioid Use Disorder Patients: A Retrospective Cohort Study.

Substance use & misuse·2026
Same journal

Parental Beliefs in Relation to Sexual Minority Young Adults' Critical Consciousness, Mental Health, and Substance Use.

Substance use & misuse·2026
Same journal

Mistaken Identity: A Prevalence Study of Bromazolam in the American Great Lakes Region.

Substance use & misuse·2026
Same journal

Autistic Trait Dimensions and Alcohol Use in College Attending Emerging Adults.

Substance use & misuse·2026
Same journal

Social Network Characteristics as Predictors of Opioid Use Disorder Treatment Utilization among People Who Use Drugs with Hepatitis C Infections in Baltimore, MD.

Substance use & misuse·2026
Same journal

Ethnicity, Gender, and Perceptions of Alcohol Users: A Vignette Study.

Substance use & misuse·2026
查看所有相关文章

相关实验视频

Updated: Jan 18, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.7K

减少患有C型肝炎的患者的酒精使用

A Giannopoulos1, J C Elliott1, N Viscaino1

  • 1Molloy University1000 Hempstead Avenue, Rockville CentreNY11570.

Substance use & misuse
|January 16, 2026
PubMed
概括
此摘要是机器生成的。

心理社会干预措施有效地减少了慢性肝炎C病毒 (HCV) 和HIV/HCV联合感染的个体的酒精消费. 这些干预措施改善了戒酒率和参与酒精治疗,有利于整体健康.

关键词:
酒精干预措施 干预措施艾滋病毒/HCV同时感染.在C型肝炎患者中,C型肝炎是最常见的.使用物质使用物质使用.

更多相关视频

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
10:42

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

9.5K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.0K

相关实验视频

Last Updated: Jan 18, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.7K
Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
10:42

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

9.5K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.0K

科学领域:

  • 肝病学 肝病学是一种肝病学.
  • 传染性疾病 传染性疾病
  • 成 药物 药物 药物 药物

背景情况:

  • 过度饮酒对患有慢性C型肝炎病毒 (HCV) 感染的个人构成重大风险.
  • 同时感染人类免疫缺陷病毒 (HIV) 和HCV会加剧这些风险,可能导致严重的肝损伤和死亡.
  • 从历史上看,这些人群在酒精使用管理方面没有得到足够的临床关注.

研究的目的:

  • 系统地审查和综合有关慢性HCV患者酒精干预的现有文献.
  • 专门研究针对HIV/HCV同时感染的人群量身定制的干预措施.
  • 在此主题上建立和更新以前的评论.

主要方法:

  • 进行了全面的文献搜索,以确定相关研究.
  • 包括的研究评估了饮酒减少干预措施的有效性.
  • 研究的重点是慢性HCV和HIV/HCV联合感染的人群.

主要成果:

  • 七项研究符合纳入标准:四项针对HCV,三项针对HIV/HCV联合感染.
  • 参与者对干预措施表现出显著的积极反应.
  • 关键的结果包括禁酒率的增加,酒精消费的减少,少喝大量饮酒的日子,并加强治疗参与.

结论:

  • 心理社会干预措施在慢性HCV和HIV/HCV共感染的个体中减少酒精使用方面有希望.
  • 成功减少酒精摄入量是一个关键的行为改变,对患者的健康有积极的影响.
  • 对于这些脆弱人群,需要进一步的研究和临床关注.